These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16760195)

  • 1. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.
    Lindsay K; Melsom R; Jacob BK; Mestry N
    Rheumatology (Oxford); 2006 Aug; 45(8):1048-9. PubMed ID: 16760195
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.
    Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O
    J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
    Watson P; Simler N; Screaton N; Lillicrap M
    Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 7. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
    Roos JC; Chilvers ER; Ostor AJ
    J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
    [No Abstract]   [Full Text] [Related]  

  • 8. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
    Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage activation syndrome after etanercept treatment.
    Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
    J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary rheumatoid nodules in an etanercept-treated patient.
    Hübscher O; Re R; Iotti R
    Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
    [No Abstract]   [Full Text] [Related]  

  • 14. Giant cell arteritis in a patient taking etanercept and methotrexate.
    Seton M
    J Rheumatol; 2004 Jul; 31(7):1467. PubMed ID: 15229983
    [No Abstract]   [Full Text] [Related]  

  • 15. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
    Hall HA; Zimmermann B
    Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649
    [No Abstract]   [Full Text] [Related]  

  • 17. Exacerbation of interstitial lung disease during etanercept therapy: Two cases.
    Tournadre A; Ledoux-Eberst J; Poujol D; Dubost JJ; Ristori JM; Soubrier M
    Joint Bone Spine; 2008 Mar; 75(2):215-8. PubMed ID: 17977770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can tumor necrosis factor alpha blockade predispose to severe babesiosis?
    Taiwo B; Lee C; Venkat D; Tambar S; Sutton SH
    Arthritis Rheum; 2007 Feb; 57(1):179-81. PubMed ID: 17266091
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept: anti-tumor necrosis factor therapy for rheumatoid arthritis.
    McGahan L
    Issues Emerg Health Technol; 1999 Oct; (8):1-6. PubMed ID: 11811215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.